Related Experiment Video
Updated: Sep 22, 2025
07:46
An Efficient and Flexible Cell Aggregation Method for 3D Spheroid Production
Published on: March 27, 2017
24.5K
Surface Optimization and Design Adaptation toward Spheroid Formation On-Chip
Neda Azizipour1, Rahi Avazpour2, Mohamad Sawan1,3,4
1Institut de Génie Biomédical, Polytechnique Montréal, Montréal, QC H3C 3A7, Canada.
Sensors (Basel, Switzerland)
|May 20, 2022
Summary
Uniform spheroid formation is crucial for cancer research drug testing. Surface-optimized polydimethylsiloxane (PDMS) biochips using bovine serum albumin (BSA) coating enable consistent, homogenous spheroid generation for improved preclinical models.
Area of Science:
- Biotechnology
- Materials Science
- Cancer Research
Background:
- Spheroids are vital for preclinical cancer research and drug testing.
- Spheroid uniformity (size, shape, density) is critical for reliable results.
- Controlling cell self-assembly for homogenous spheroids on polydimethylsiloxane (PDMS) is challenging.
Purpose of the Study:
- To develop surface-optimized PDMS biochips for uniform spheroid formation.
- To investigate the efficacy of surface modification in controlling cell adhesion and aggregation.
- To establish a reliable method for producing homogenous, non-scaffold-based spheroids.
Main Methods:
- Developed PDMS biochip platforms with optimized surface treatments.
- Utilized bovine serum albumin (BSA) for surface modification to suppress cell adhesion.
- Tested biochips with six human cell lines and a co-culture model for spheroid generation.
Main Results:
- Surface-optimized PDMS biochips successfully produced uniform, homogenous spheroids.
- 10% BSA coating effectively suppressed cell adhesion to PDMS surfaces.
- BSA concentration is critical; 3% BSA showed limited cell repellent properties.
Conclusions:
- Surface modification of PDMS biochips is essential for controlled spheroid formation.
- BSA-coated biochips provide a robust platform for generating uniform, non-scaffold spheroids.
- This method enhances the reliability of spheroid-based preclinical cancer drug testing.
